Immuneering Corp
Total Trades
38
Buys
34
Sells
1
Largest Trade
$1M+
Insiders
14
Institutional Funds
66
Inst. Value
$1M+
Activist Filings
24
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Brakewood Harold Eugene | Chief Business Off… | BUY | $15K–$50K | 5K | $4.76 | Jan 21, 2026 |
| Schall Thomas J. | Director | BUY | $100K–$500K | 22K | $4.67 | Jan 20, 2026 |
| Hall Brett Matthew | CHIEF SCIENTIFIC O… | BUY | $1K–$15K | 2K | $4.57 | Jan 16, 2026 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | BUY | $1K–$15K | 3K | $4.15 | Jan 15, 2026 |
| Feinberg Peter | Director | BUY | $50K–$100K | 20K | $4.35 | Jan 14, 2026 |
| Morales Mallory | Chief Accounting O… | BUY | $1K–$15K | 300 | $6.39 | Oct 2, 2025 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | BUY | $1K–$15K | 800 | $6.38 | Oct 2, 2025 |
| Bookman Michael | CHIEF LEGAL OFFICER | BUY | $1K–$15K | 1K | $6.83 | Oct 2, 2025 |
| Feinberg Peter | Director | BUY | $50K–$100K | 8K | $7.03 | Oct 1, 2025 |
| Feinberg Peter | Director | BUY | $15K–$50K | 5K | $7.18 | Sep 30, 2025 |
| HAUSMAN DIANA | Director | BUY | $15K–$50K | 6K | $3.61 | Jul 7, 2025 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | BUY | $1K–$15K | 700 | $3.57 | Jul 7, 2025 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | BUY | $15K–$50K | 10K | $3.49 | Jul 3, 2025 |
| Schall Thomas J. | Director | BUY | $15K–$50K | 10K | $3.66 | Jun 30, 2025 |
| Hall Brett Matthew | CHIEF SCIENTIFIC O… | BUY | $15K–$50K | 13K | $2.58 | Jun 24, 2025 |
| Brakewood Harold Eugene | Chief Business Off… | BUY | $1K–$15K | 2K | $2.53 | Jun 24, 2025 |
| Feinberg Peter | Director | BUY | $50K–$100K | 25K | $2.53 | Jun 23, 2025 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | BUY | $50K–$100K | 21K | $2.39 | Jun 20, 2025 |
| Schall Thomas J. | Director | BUY | $50K–$100K | 40K | $2.21 | Jun 18, 2025 |
| Cormorant Asset Management, LP | 10% Owner | SELL | $1M+ | 400K | $2.90 | Apr 3, 2024 |
| Schall Thomas J. | Director | BUY | $1K–$15K | 3K | $2.55 | Mar 25, 2024 |
| Feinberg Peter | Director | BUY | $50K–$100K | 25K | $2.55 | Mar 25, 2024 |
| Brakewood Harold Eugene | Chief Business Off… | BUY | $1K–$15K | 4K | $2.57 | Mar 25, 2024 |
| Morales Mallory | Chief Accounting O… | BUY | $1K–$15K | 2K | $2.67 | Mar 25, 2024 |
| Morales Mallory | Chief Accounting O… | GRANT | $1K–$15K | 4K | $1.62 | Mar 25, 2024 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | GRANT | $1K–$15K | 6K | $1.62 | Mar 21, 2024 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | BUY | $1K–$15K | 4K | $2.88 | Mar 21, 2024 |
| Hall Brett Matthew | CHIEF SCIENTIFIC O… | BUY | $15K–$50K | 7K | $2.86 | Mar 21, 2024 |
| Hall Brett Matthew | CHIEF SCIENTIFIC O… | GRANT | $1K–$15K | 6K | $1.62 | Mar 21, 2024 |
| Hall Brett Matthew | CHIEF SCIENTIFIC O… | BUY | $1K–$15K | 3K | $3.92 | May 27, 2022 |
| Bookman Michael | GENERAL COUNSEL AN… | BUY | $1K–$15K | 1K | $4.88 | May 18, 2022 |
| KEATING LAURIE | Director | BUY | $15K–$50K | 7K | $5.00 | May 17, 2022 |
| Amin Biren | CFO, TREASURER | BUY | $1K–$15K | 1K | $4.42 | May 12, 2022 |
| Zeskind Benjamin J. | PRESIDENT AND CEO | BUY | $15K–$50K | 3K | $8.02 | Mar 24, 2022 |
| Hall Brett Matthew | CHIEF SCIENTIFIC O… | BUY | $1K–$15K | 1K | $7.91 | Mar 23, 2022 |
| Barrett Scott | CHIEF MEDICAL OFFI… | BUY | $1K–$15K | 900 | $7.49 | Mar 22, 2022 |
| Feinberg Peter | Director | BUY | $15K–$50K | 7K | $6.75 | Mar 16, 2022 |
| BERMAN ANN E | Director | BUY | $15K–$50K | 6K | $6.40 | Mar 15, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 66 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Sanofi | 2.7M | $1M+ | SH |
| Empery Asset Management, LP | 2.7M | $1M+ | SH |
| STATE STREET CORP | 2.4M | $1M+ | SH |
| VANGUARD GROUP INC | 2.2M | $1M+ | SH |
| Blue Owl Capital Holdings LP | 665K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 665K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 501K | $1M+ | SH |
| Occam Crest Management LP | 498K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 319K | $1M+ | SH |
| Burkehill Global Management, LP | 300K | $1M+ | SH |
| SOUTHPORT MANAGEMENT, L.L.C. | 278K | $1M+ | SH |
| Diametric Capital, LP | 247K | $1M+ | SH |
| DCF Advisers, LLC | 215K | $1M+ | SH |
| BARCLAYS PLC | 166K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 152K | $1M+ | SH |
| UBS Group AG | 148K | $500K+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 133K | $500K+ | SH |
| Rafferty Asset Management, LLC | 131K | $500K+ | SH |
| Kingsview Wealth Management, LLC | 119K | $500K+ | SH |
| TD ASSET MANAGEMENT INC | 118K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jan 22, 2026
6.6%
4.4M shares
SC 13G/A · Jan 15, 2026
5.0%
3.3M shares
SC 13G · Oct 21, 2025
8.8%
5.2M shares
SC 13G · Oct 7, 2025
14.5%
8.8M shares
HBM Healthcare Investments (Cayman) Ltd.
SC 13G · Oct 3, 2025
5.7%
3.6M shares
SC 13G/A · Jan 17, 2025
12.8%
4.0M shares
SC 13G/A · Nov 14, 2024
0.0%
6 shares
Cormorant Asset Management, LP
SC 13G/A · Nov 14, 2024
0.0%
0 shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Apr 15, 2024
1.9%
561K shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Apr 10, 2024
3.1%
910K shares
SC 13G/A · Apr 5, 2024
4.7%
1.4M shares
SC 13G/A · Mar 27, 2024
9.5%
2.8M shares
SC 13G/A · Feb 14, 2024
7.0%
6 shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2024
11.5%
3.4M shares
SC 13G · Jan 26, 2024
7.2%
2.1M shares
SC 13G/A · May 5, 2023
4.6%
1.3M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Apr 24, 2023
6.8%
2.0M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2023
3.7%
988K shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
13.7%
3.6M shares
SC 13G/A · Feb 14, 2023
7.8%
6 shares
SC 13G/A · Feb 1, 2023
5.1%
1.3M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
12.2%
3.2M shares
SC 13G/A · Feb 14, 2022
7.8%
6 shares
SC 13G · Feb 10, 2022
12.7%
3.4M shares